{"entity":{"id":209,"urn":"wenzhou-city-trust:org.school:温州医科大学","name":"温州医科大学","slug":"wen-zhou-yi-ke-da-xue","lede":"与浙江省海洋水产养殖研究所合作，研究坛紫菜藻红蛋白对酒精性肝损伤的修复作用。","seedSource":"import","attrsJson":{"type":"企业组织","region":"温州"},"status":"published","revision":1,"publishedAt":"2026-10-26T20:13:17.000Z","datasetId":1,"datasetCode":"wenzhou-city-trust","datasetName":"温州城市可信数据集","categoryId":31,"categoryName":"企业组织","categoryCode":"org"},"fact":{"id":6235,"entityId":209,"code":"global-F-000209-04","dimensionId":6,"dimension":"work","statement":"温州医科大学以李校堃院士团队为核心，依托“细胞生长因子药物和蛋白制剂国家工程研究中心”等国家级平台，提供源头创新技术，聚焦FGF在抗衰老、代谢疾病等领域的基础研究与技术攻关。","factType":"current_state","status":"active","reviewStatus":"approved","publicationStatus":"published","signedAt":"2026-11-21T03:11:39.000Z","signedBy":null,"statementKind":"claim","confidence":0.9,"corroborateCount":1,"firstSeenAt":"2026-11-21","lastVerifiedAt":"2026-11-21","validFrom":null,"validTo":null,"supersededById":null,"version":1,"arbitrationNote":"描述温州医科大学在合作机制中的职能定位，属于现状定性，且为新的工作维度事实。","semanticRole":"definition","periodKey":null,"subjectScope":"校企地合作机制中的高校角色","timePrecision":"unknown","timeCertainty":"unknown","origin":"llm","createdBy":null,"updatedBy":null,"createdAt":"2026-11-21T03:08:47.000Z","updatedAt":"2026-11-21T04:08:21.000Z","temporalKind":"effective","asOf":null,"eventStart":null,"eventEnd":null,"method":"ai抽取待核","signMode":"auto","sourceAuthority":null,"independentlyVerified":false,"issuedAt":"2026-11-21T03:11:39.000Z","alerts":[],"canonicalFactId":null,"evidences":[{"factId":6235,"role":"support","id":14805,"code":"wenzhou-city-trust-E-000209-05","quote":"温州医科大学以李校堃院士团队为核心，依托“细胞生长因子药物和蛋白制剂国家工程研究中心”等国家级平台，提供源头创新技术，聚焦FGF在抗衰老、代谢疾病等领域的基础研究与技术攻关，培养专业人才，推行“科技副总+产业教授”双轨制。","spanStart":474,"spanEnd":585,"spanHash":"74d2948ed0431d92caf6aa7daa5016b0d0efa6150d7ad9afbcdfacf482239e86","verifyStatus":"passed","qualityGrade":"A","articleId":2584,"materialTitle":"高校如何赋能地方产业发展？“生长因子”之城树立“校企地”合作样本","sourceOrg":"温度新闻客户端","publishedAt":"2026-11-21"}],"applicability":{"key":"current","label":"按已发依据适用 · 未独立现场复核","color":"green"},"revisions":[{"id":6137,"factId":6235,"rev":1,"statement":"温州医科大学以李校堃院士团队为核心，依托“细胞生长因子药物和蛋白制剂国家工程研究中心”等国家级平台，提供源头创新技术，聚焦FGF在抗衰老、代谢疾病等领域的基础研究与技术攻关。","dimension":"work","factType":"current_state","confidence":0.9,"temporalKind":"effective","asOf":null,"eventStart":null,"eventEnd":null,"validFrom":null,"validTo":null,"qualifier":"校企地合作机制中的高校角色","evidenceIds":[],"method":"ai抽取待核","signMode":"auto","sourceAuthority":null,"independentlyVerified":false,"actor":null,"release":"draft","changeType":"initial","reason":"描述温州医科大学在合作机制中的职能定位，属于现状定性，且为新的工作维度事实。","issuedAt":null,"createdAt":"2026-11-21T03:08:47.000Z"}],"relations":[]},"permalink":"/archive/wenzhou-city-trust/wen-zhou-yi-ke-da-xue/fact/global-F-000209-04"}